Pregnancy-related immune suppression leads to altered influenza vaccine recall responses
File(s)YCLIM_108254_edit_report.pdf (1.67 MB) Rights & Access.pdf (79.39 KB)
Accepted version
Supporting information
Author(s)
Shah, Nishel M
Imami, Nesrina
Kelleher, Peter
Barclay, Wendy S
Johnson, Mark R
Type
Journal Article
Abstract
Pregnancy is a risk factor for severe influenza infection. Despite achieving seroprotective antibody titres post immunisation fewer pregnant women experience a reduction in influenza-like illness compared to non-pregnant cohorts. This may be due to the effects that immune-modulation in pregnancy has on vaccine efficacy leading to a less favourable immunologic response.
To understand this, we investigated the antigen-specific cellular responses and leukocyte phenotype in pregnant and non-pregnant women who achieved seroprotection post immunisation. We show that pregnancy is associated with better antigen-specific inflammatory (IFN-γ) responses and an expansion of central memory T cells (Tcm) post immunisation, but low-level pregnancy-related immune regulation (HLA-G, PIBF) and associated reduced B-cell antibody maintenance (TGF-β) suggest poor immunologic responses compared to the non-pregnant.
Thus far, studies of influenza vaccine immunogenicity have focused on the induction of antibodies but understanding additional vaccine-related cellular responses is needed to fully appreciate how pregnancy impacts on vaccine effectiveness.
To understand this, we investigated the antigen-specific cellular responses and leukocyte phenotype in pregnant and non-pregnant women who achieved seroprotection post immunisation. We show that pregnancy is associated with better antigen-specific inflammatory (IFN-γ) responses and an expansion of central memory T cells (Tcm) post immunisation, but low-level pregnancy-related immune regulation (HLA-G, PIBF) and associated reduced B-cell antibody maintenance (TGF-β) suggest poor immunologic responses compared to the non-pregnant.
Thus far, studies of influenza vaccine immunogenicity have focused on the induction of antibodies but understanding additional vaccine-related cellular responses is needed to fully appreciate how pregnancy impacts on vaccine effectiveness.
Date Issued
2019-11-01
Date Acceptance
2019-08-26
Citation
Clinical Immunology, 2019, 208
ISSN
1521-6616
Publisher
Elsevier BV
Journal / Book Title
Clinical Immunology
Volume
208
Copyright Statement
© 2019 Elsevier Inc. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Sponsor
Imperial College Trust
Grant Number
Mark Johnson's IC Trust Acct
Subjects
Influenza
Pregnancy
Tolerance
Vaccination
1107 Immunology
Immunology
Publication Status
Published
Article Number
ARTN 108254
Date Publish Online
2019-08-27